[Apropos of the monitoring of treatment with low molecular weight heparins].
Toulemonde
F
F
Institut Choay-Sanofi, Gentilly.
Bayrou
B
B
D015951:Factor Xa / Q000032:analysis; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008991:Monitoring, Physiologic; D010689:Phlebitis / Q000188:drug therapy; D011655:Pulmonary Embolism / Q000188:drug therapy
D006495:Heparin, Low-Molecular-Weight; D015951:Factor Xa
A propos de la surveillance des traitements par les héparines de bas poids moléculaire (HBPM).